This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Vanderbilt University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: J Phillip Kennedy: Innovator in Quinazoline Compounds
Introduction
J Phillip Kennedy is a notable inventor based in Nashville, TN (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of quinazoline compounds. His work focuses on modulating Ras signaling, which is crucial in various disease states.
Latest Patents
Kennedy holds a patent for "Quinazoline compounds as modulators of Ras signaling." This invention relates to quinazoline compounds and compositions that modulate Ras signaling. The compounds and compositions are useful in treating cancers and other diseases associated with Ras dysfunction, such as Ras-associated autoimmune leukoproliferative disorder and certain types of mitochondrial dysfunction in subjects, including mammals and humans. He has 1 patent to his name.
Career Highlights
J Phillip Kennedy is affiliated with Vanderbilt University, where he conducts his research and development work. His role at the university allows him to collaborate with other experts in the field and contribute to advancements in medical science.
Collaborations
Some of his notable coworkers include Alex Gregory Waterson and Jason R Abbott. Their collaborative efforts enhance the research environment and foster innovation in their respective fields.
Conclusion
J Phillip Kennedy's work in quinazoline compounds represents a significant advancement in the treatment of diseases related to Ras dysfunction. His contributions to medicinal chemistry continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile